Southeast Asset Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Southeast Asset Advisors's LLY Position: Q1 2026 in Review
Southeast Asset Advisors reduced its Eli Lilly (LLY) stake by 0.07% in Q1 2026, selling an estimated $2.03K and leaving 2,848 shares worth $2.62M. The position accounts for 0.29% of the portfolio, ranked #54.
Southeast Asset Advisors first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.27M in Q3 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Southeast Asset Advisors held 2,848 shares of Eli Lilly worth $2.62M as of Q1 2026.
- Southeast Asset Advisors sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
- Eli Lilly made up 0.29% of Southeast Asset Advisors's portfolio in Q1 2026, its #54 holding.
- Southeast Asset Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
- Southeast Asset Advisors's Eli Lilly position peaked at $3.27M in Q3 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Southeast Asset Advisors's 13F filing for Q1 2026, filed 13 May 2026.